Topic Summary:  A science-driven look at how incredibly tiny gold particles can be used in the treatment of cancer.

Dr Karolina Valente is an assistant Professor in the Mechanical Engineering Department at the University of Victoria.  She is also the CEO, President and Co-founder of VoxCell BioInnovation.  VoxCell BioInnovation is a biotechnology start-up located in Victoria, BC focused on the development of a high resolution bioprinter capable of creating human tissue models with vasaculture.  These tissues will disrupt the drug development industry by proving complex models for invitro drug testing.  With VoxCell's bioprinter and tissue models, they aim to dramatically reduce the time and resources spent in pre-clinical trials and increase the successful transition between pre-clinical trial data and clinical trial results.  Their mission is to accelerate the tissue engineering and drug development fields with truly biomimetric solutions.